A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose
Public ClinicalTrials.gov record NCT00202982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy, Tolerability and Safety of 40 mg of Copaxone in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to test if a new higher dose of Copaxone is more effective in treating relapsing-remitting multiple sclerosis than the currently available 20 mg dose.
Study identification
- NCT ID
- NCT00202982
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2003
- Primary completion
- Aug 31, 2005
- Completion
- Aug 31, 2005
- Last update posted
- Jan 13, 2010
2003 – 2005
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Neurologic Study | La Jolla | California | 92037 | — |
| North County Neurology Associates | Oceanside | California | 92056 | — |
| The MS Center of Atlanta | Atlanta | Georgia | — | — |
| Consultants in Neurology, Ltd | Northbrook | Illinois | 60062 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| The Maryland Center for M.S. | Baltimore | Maryland | — | — |
| Michigan Institute of Neurological Disorders | Farmington Hills | Michigan | 48334 | — |
| The Minneapolis Clinic of Neurology, LTD | Golden Valley | Minnesota | 55422 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| St. John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| Clinical & Magnetic Resonance Research Ctr. | Albuquerque | New Mexico | 87131 | — |
| MSSM - Corinne Goldsmith Dickinson Center for MS | New York | New York | 10029 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Geisinger Medical Center | Danville | Pennsylvania | 17822 | — |
| Allegheny Neurological Associates | Pittsburgh | Pennsylvania | 15212 | — |
| University of Tennessee | Memphis | Tennessee | 38163 | — |
| VAMC | Salt Lake City | Utah | 84148 | — |
| MS Hub Medical Group | Seattle | Washington | 98101 | — |
| Neurology & Neurosurgery | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00202982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2010 · Synced Sep 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00202982 live on ClinicalTrials.gov.